Dashboard
Manage Tickers

ANNXAnnexon, Inc.

Nasdaq annexonbio.com


$ 5.74 $ -0.15 (-2.55 %)    

Friday, 07-Jun-2024 15:59:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 462.76 $ -0.41 (-0.09 %)
DIA $ 388.38 $ -0.84 (-0.22 %)
SPY $ 533.54 $ -0.65 (-0.12 %)
TLT $ 91.51 $ -1.71 (-1.83 %)
GLD $ 211.60 $ -7.83 (-3.57 %)
$ 5.74
$ 5.81
$ 0.00 x 0
$ 0.00 x 0
$ 5.34 - $ 5.82
$ 1.57 - $ 8.40
4,615,078
na
704.14M
$ 1.19
$ 52.16
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-06-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 09-08-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-earlier-annexon-prices-125m-underwritten-public-offering-of-13001120-common-shares-at-625share
Reported Earlier, Annexon Prices $125M Und...
06/06/2024 06:12:34

The pricing of its previously announced underwritten public offering of 13,001,120 shares of its common stock at a price to the...

cantor-fitzgerald-reiterates-overweight-on-annexon
Cantor Fitzgerald Reiterates Overweight on...
06/05/2024 13:55:14

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.

douyu-international-posts-q1-results-joins-annexon-dollar-tree-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
DouYu International Posts Q1 Results, Join...
06/05/2024 12:07:39

annexon-shares-are-trading-lower-after-the-company-announced-the-commencement-of-a-125-million-public-offering
Annexon shares are trading lower after the...
06/05/2024 12:07:23

why-stitch-fix-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Stitch Fix Shares Are Trading Higher B...
06/05/2024 09:27:25

annexon-commences-public-offering-of-125m-of-shares-of-its-common-stock
Annexon Commences Public Offering Of $125M...
06/04/2024 21:09:36

All of the shares are being offered by Annexon. In addition, Annexon expects to grant the underwriters a 30-day option to purch...

needham-reiterates-buy-on-annexon-maintains-16-price-target
Needham Reiterates Buy on Annexon, Maintai...
06/04/2024 19:16:54

Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.

hc-wainwright--co-reiterates-buy-on-annexon-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Anne...
06/04/2024 18:57:42

HC Wainwright & Co. analyst Andrew Fein reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $30 price target.

dow-surges-200-points-designer-brands-shares-plunge-following-q1-earnings
Dow Surges 200 Points; Designer Brands Sha...
06/04/2024 18:32:30

why-core--main-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Core & Main Shares Are Trading Lower B...
06/04/2024 16:54:09

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 16:31:07

mid-cap-firm-annexons-nerve-disorder-candidate-shows-promise-in-pivotal-late-stage-study
Mid-Cap Firm Annexon's Nerve Disorder Cand...
06/04/2024 16:06:20

Annexon reports positive Phase 3 trial results for ANX005 in Guillain-Barré syndrome, showing significant improvements in disab...

gold-down-1-bath--body-works-shares-tumble-after-q1-results
Gold Down 1%; Bath & Body Works Shares Tum...
06/04/2024 16:00:38

saia-annexon-core-scientific-and-other-big-stocks-moving-higher-on-tuesday
Saia, Annexon, Core Scientific And Other B...
06/04/2024 14:08:59

Core News & Articles
Market-Moving News for June 4th
06/04/2024 12:36:59

AX: -21% | Watching Axos Financial; Hindenburg Research Issues Report On Co Titled "Axos: Glaring Commercial Real Estate Lo...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 12:06:42

annexon-says-anx005-75-mgkg-outperformed-placebo-on-multiple-endpoints-however-it-was-not-statistically-significant-on-the-primary-endpoint-of-gbs-ds-at-week-8
Annexon Says "ANX005 75 mg/kg outperformed...
06/04/2024 11:03:42

annexon-announces-phase-3-anx005-trial-in-guillain-barr-syndrome-met-primary-endpoint
Annexon Announces Phase 3 ANX005 Trial In ...
06/04/2024 11:00:52

why-healthequity-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why HealthEquity Shares Are Trading Higher...
06/04/2024 09:50:06

wells-fargo-maintains-overweight-on-annexon-lowers-price-target-to-10
Wells Fargo Maintains Overweight on Annexo...
05/15/2024 18:12:27

Wells Fargo analyst Derek Archila maintains Annexon (NASDAQ:ANNX) with a Overweight and lowers the price target from $12 to ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION